Today: 9 April 2026
Lam Research stock price pops into long weekend — here’s what to watch next week

Lam Research stock price pops into long weekend — here’s what to watch next week

New York, Jan 17, 2026, 12:21 ET — Market closed

  • Lam Research gained 2.5% on Friday, pushing its semiconductor-equipment rally further.
  • Traders linked the move to a surge in chipmaker spending, spearheaded by TSMC’s capex plan for 2026.
  • Attention shifts to late-month updates from chip toolmakers, with Lam’s results in the spotlight.

Shares of Lam Research (LRCX.O) climbed 2.5% on Friday, finishing at $222.96, as U.S. markets remained closed over the weekend.

The stock has rallied alongside other chip-equipment firms after Taiwan Semiconductor Manufacturing Co raised its 2026 capital spending forecast to $52 billion-$56 billion. Investors took this as a signal of increased demand for chipmaking tools. “The market has underestimated again how large is the demand for AI, and the implementation is going faster than everybody expected,” said Han Dieperink, chief investment officer at Aureus, which holds shares in ASML. Reuters

Chip stocks lifted Wall Street on Thursday, snapping a two-day skid as TSMC’s forecast and bank earnings steadied investor nerves. “That’s been kind of squashed this morning with the news from Taiwan Semiconductor,” said Alan Lancz, president of Alan B. Lancz & Associates, referring to earlier tech valuation concerns. Reuters

Friday’s trading was volatile and barely moved the major indexes, yet chipmakers pushed higher. The Philadelphia SE Semiconductor index climbed 1.2%, building on gains from Thursday. U.S. markets will be closed Monday for the Martin Luther King Jr. holiday, tightening next week’s schedule as earnings season heats up. Reuters

Peers wrapped up Friday on an upswing as well: Applied Materials (AMAT.O) climbed 2.5%, KLA (KLAC.O) edged up 1.4%, and ASML’s U.S.-listed shares (ASML.O) rose roughly 2.1%.

Behind the scenes, bullish sentiment has been steadily building. Dhierin Bechai, writing for Seeking Alpha on Thursday, upgraded Lam Research to a Buy. He cited growing expectations for spending on wafer-fab equipment — the gear that fabricates chips on silicon wafers — along with tightening supply conditions in memory. Seeking Alpha

Lam ranks among the top suppliers of etch and deposition equipment critical for advanced logic and memory chip production, positioning its stock as a barometer for major chipmakers’ spending pace. Typically, when customers signal plans to ramp up capacity, the tool suppliers react ahead of the curve.

When the market reopens Tuesday, traders will be sizing up whether TSMC’s spending plan signals a lasting boost in 2026 orders or just a temporary sentiment spike that fades once investors scrutinize the fine print.

But the setup works both ways. Tool stocks can lose gains quickly if chipmakers push back projects, memory spending falters, or macro shocks weigh on the high-multiple tech sector. A strong rally ahead of earnings also amps up expectations for guidance.

Lam’s quarterly financial conference call and webcast is set for Wednesday, Jan. 28, after the market closes. Investors will be keen to catch any hints from customers about 2026 spending plans and delivery schedules. investor.lamresearch.com

Stock Market Today

  • Fossil Group Shares Surge 8.3% Amid Mixed Earnings Outlook
    April 9, 2026, 9:16 AM EDT. Fossil Group (FOSL) shares jumped 8.3% to close at $5.2 on heavy volume, extending a 19.1% gain over the past month. Despite this rally, the watchmaker is expected to report a quarterly loss of $0.22 per share, a 120% decline year over year, with revenues down 12% to $205.3 million. Consensus earnings estimates have been revised sharply lower by 236.4% in the last 30 days, typically a bearish signal. Fossil is focusing on a brand-led turnaround with full-price sales and cost tightening to support margins and growth, particularly in the U.S. and India. The stock retains a Zacks Rank #3 (Hold). Peer Urban Outfitters (URBN) gained 5.4%, but its earnings forecasts also declined slightly. Investors should watch if Fossil's price momentum can withstand its weak earnings forecast.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
HSBC share price in focus after Singapore insurance review as markets head into week ahead
Previous Story

HSBC share price in focus after Singapore insurance review as markets head into week ahead

Novartis stock set for holiday-thinned week after FDA breakthrough tag for Sjögren’s drug
Next Story

Novartis stock set for holiday-thinned week after FDA breakthrough tag for Sjögren’s drug

Go toTop